COH.AX COCHLEAR FPO [COH] | AU000000COH5
Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Latest News
Goldman Sachs leads oil and gas M&A advisory by value in H1 2026
Offshore Technology • 07/27/2026
Philippines' Marcos says 'perhaps time to revisit nuclear energy'
AFP • 07/27/2026
Camden National Bank Earnings: What To Look For From CAC
StockStory • 07/27/2026
Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26
ACCESS Newswire • 07/27/2026
Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
PR Newswire • 07/27/2026
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.cochlear.com |
| Audit Risk | 2 |
| Board Risk | 1 |
| Overall Risk | 1 |
| Market Cap | 7.49B |
| Trailing P/E | 21.69 |
| Forward P/E | 22.19 |
| Dividend Rate | 4.3 |
| Dividend Yield | 3.76% |
| Trailing Annual Div. Rate | 4.3 |
| Trailing Annual Div. Yield | 3.85% |
| Trailing EPS | 5.28 |
| Forward EPS | 5.16 |
| Book Value | 29.63 |
| Price-to-Book | 3.86 |
| Enterprise-to-Revenue | 3.15 |
| Enterprise-to-EBITDA | 13.09 |
| Ex-Dividend Date | 03/19/2026 |
| Earnings Date | 08/18/2026 |
| Earnings Call Date |